SCHEMBL18852905

SCHEMBL18852905

c1ccc(-c2ccc(-c3nc(-c4ccccc4)c4sc5ccc6ccccc6c5c4n3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ ATM Q13315 1/20 0.40
▸ CYP1A2 P05177 3/20 0.36
▸ CYP1A1 P04798 2/20 0.36
▸ CYP1B1 Q16678 2/20 0.36
▸ MAPT P10636 5/20 0.35
▸ LMNA P02545 2/20 0.35
▸ RECQL P46063 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ LIMK1 P53667 2/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ MMP14 P50281 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GAA P10253 2/20 0.33
▸ ALDH1A1 P00352 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18853028 1.00 MEN1 (0.40) MEN1KMT2AATMCYP1A2CYP1A1
SCHEMBL19106330 0.97 MEN1 (0.43) MEN1KMT2AATMCYP1A2CYP1A1
SCHEMBL18853024 0.97 MEN1 (0.38) MEN1KMT2AATMCYP1A2CYP1A1
SCHEMBL19106724 0.94 MEN1 (0.50) MEN1KMT2AATMCYP1A2CYP1A1
SCHEMBL19106338 0.93 MEN1 (0.51) MEN1KMT2AATMCYP1A2CYP1A1
SCHEMBL18853036 0.93 LIMK1 (0.38) MEN1KMT2AATMCYP1A2CYP1A1
SCHEMBL18853025 0.93 LIMK1 (0.38) MEN1KMT2AATMCYP1A2CYP1A1
SCHEMBL18852930 0.91 CYP1A1 (0.36) MEN1KMT2AATMCYP1A2CYP1A1
SCHEMBL18853023 0.91 CYP1A1 (0.36) MEN1KMT2AATMCYP1A2CYP1A1
SCHEMBL18852881 0.91 CYP1A1 (0.36) MEN1KMT2AATMCYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680190-B2 Organic compound, organic optoelectronic element, and display device SAMSUNG SDI CO., LTD. (KR) 2020-06-09 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 MEN1 1335/4885KMT2A 3186/4885ATM 4486/4885
US-10680190-B2 Organic compound, organic optoelectronic element, and display device OCIAD1, OXER1, OCIAD2 MEN1 1335/4885KMT2A 3186/4885ATM 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback